Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilles, R.
Right arrow Articles by Vanel, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilles, R.
Right arrow Articles by Vanel, D.

Radiology, Vol 191, 633-638, Copyright © 1994 by Radiological Society of North America

ARTICLES

Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy

R Gilles, JM Guinebretiere, C Toussaint, M Spielman, M Rietjens, JY Petit, G Contesso, J Masselot and D Vanel
Department of Radiology, Institut Gustave Roussy, Villejuif, France.

PURPOSE: To determine the value of contrast material-enhanced subtraction magnetic resonance (MR) imaging in assessment of response to chemotherapy in locally advanced breast cancer. MATERIALS AND METHODS: Eighteen women treated with chemotherapy because of locally advanced breast cancer underwent preoperative MR examination including both routine and dynamic MR sequences after injection of gadolinium tetraazacyclododecanetetraacetic acid. Any early contrast enhancement, concomitant with early vascular enhancement during the dynamic MR study, was considered pathologic. RESULTS: Dynamic MR studies showed early contrast enhancement in all women with residual tumor except one with nodular residual tumor. Histopathologic analysis and dynamic MR images of contrast-enhanced lesions correlated well, but in one patient, intraductal extension was not seen on MR images, and in another, additional isolated tumor cells were seen in the histologic specimen. Subtraction images always facilitated visualization of vascular and pathologic contrast enhancement. CONCLUSION: Dynamic MR contrast-enhanced subtraction studies are useful in assessment of residual tumor after chemotherapy.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
J. Hattangadi, C. Park, J. Rembert, C. Klifa, J. Hwang, J. Gibbs, and N. Hylton
Breast Stromal Enhancement on MRI Is Associated with Response to Neoadjuvant Chemotherapy
Am. J. Roentgenol., June 1, 2008; 190(6): 1630 - 1636.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff
Locally Advanced and Inflammatory Breast Cancer
J. Clin. Oncol., February 10, 2008; 26(5): 786 - 790.
[Full Text] [PDF]

Home page
 RadiologyHome page
S. P. Poplack, T. D. Tosteson, W. A. Wells, B. W. Pogue, P. M. Meaney, A. Hartov, C. A. Kogel, S. K. Soho, J. J. Gibson, and K. D. Paulsen
Electromagnetic Breast Imaging: Results of a Pilot Study in Women with Abnormal Mammograms
Radiology, May 1, 2007; 243(2): 350 - 359.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, et al.
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
CA Cancer J Clin, March 1, 2007; 57(2): 75 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Tripathy, D. S. Wolverton, H. S. Rugo, E. S. Hwang, C. A. Ewing, and N. M. Hylton
MRI Measurements of Breast Tumor Volume Predict Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival
Am. J. Roentgenol., June 1, 2005; 184(6): 1774 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian
Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer
Am. J. Roentgenol., March 1, 2005; 184(3): 868 - 877.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. Meisamy, P. J. Bolan, E. H. Baker, R. L. Bliss, E. Gulbahce, L. I. Everson, M. T. Nelson, T. H. Emory, T. M. Tuttle, D. Yee, et al.
Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo 1H MR Spectroscopy--A Pilot Study at 4 T
Radiology, November 1, 2004; 233(2): 424 - 431.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. Thibault, C. Nos, M. Meunier, C. El Khoury, L. Ollivier, B. Sigal-Zafrani, and K. Clough
MRI for Surgical Planning in Patients with Breast Cancer Who Undergo Preoperative Chemotherapy
Am. J. Roentgenol., October 1, 2004; 183(4): 1159 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S.-J. Kim, S.-k. Kim, E. S. Lee, J. Ro, and S. h. Kang
Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy
Ann. Onc., September 1, 2004; 15(9): 1352 - 1357.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. A. Mankoff, L. K. Dunnwald, J. R. Gralow, G. K. Ellis, E. K. Schubert, J. Tseng, T. J. Lawton, H. M. Linden, and R. B. Livingston
Changes in Blood Flow and Metabolism in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy
J. Nucl. Med., November 1, 2003; 44(11): 1806 - 1814.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J.-P. Delille, P. J. Slanetz, E. D. Yeh, E. F. Halpern, D. B. Kopans, and L. Garrido
Invasive Ductal Breast Carcinoma Response to Neoadjuvant Chemotherapy: Noninvasive Monitoring with Functional MR Imaging— Pilot Study
Radiology, July 1, 2003; 228(1): 63 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Sudilovsky, and N. M. Hylton
Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients Who Have Undergone Neoadjuvant Chemotherapy
Am. J. Roentgenol., November 1, 2002; 179(5): 1193 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
I. Gunhan-Bilgen, E. E. Ustun, and A. Memis
Inflammatory Breast Carcinoma: Mammographic, Ultrasonographic, Clinical, and Pathologic Findings in 142 Cases
Radiology, June 1, 2002; 223(3): 829 - 838.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. A. Mankoff, L. K. Dunnwald, J. R. Gralow, G. K. Ellis, A. Charlop, T. J. Lawton, E. K. Schubert, J. Tseng, and R. B. Livingston
Blood Flow and Metabolism in Locally Advanced Breast Cancer: Relationship to Response to Therapy
J. Nucl. Med., April 1, 2002; 43(4): 500 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
L. Esserman, E. Kaplan, S. Partridge, D. Tripathy, H. Rugo, J. Park, S. Hwang, H. Kuerer, D. Sudilovsky, Y. Lu, et al.
MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer
Ann. Surg. Oncol., July 1, 2001; 8(6): 549 - 559.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. G. Orel and M. D. Schnall
MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer
Radiology, July 1, 2001; 220(1): 13 - 30.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1994 by the Radiological Society of North America.